Clinical Significance of Body Surface Area (BSA)
Body Surface Area (BSA) quantifies the total measured surface area of a human body in square meters (m²). In modern pharmacotherapy, intensive care medicine, and nephrology, BSA is deemed a significantly superior metric for metabolic mass and biological clearance than gross body weight alone. Adipose tissue has markedly lower metabolic perfusion and drug clearance compared to vascularized lean parenchyma.
1. Oncology Chemotherapy
Narrow-therapeutic-index chemotherapeutic antineoplastic agents (e.g., cisplatin, doxorubicin, paclitaxel) are universally dosed in milligrams per square meter (mg/m²) to minimize organ toxicity while preventing underdosing.
2. Hemodynamics & Cardiac Index
Cardiac Output (CO in L/min) divided by BSA yields the Cardiac Index (CI), standardizing hemodynamic perfusion regardless of body height and skeletal stature (Normal CI: 2.6 - 4.2 L/min/m²).
3. Renal GFR Normalization
Clearance biomarkers such as Glomerular Filtration Rate are uniformly indexed to the standardized reference adult surface area of 1.73 m².
Why Mosteller is the Clinical Standard
Published in 1987 in The New England Journal of Medicine, the Mosteller formula: BSA (m²) = √[(Height(cm) × Weight(kg)) / 3600] demonstrated near-perfect correlation with classical 1916 Du Bois measurements while reducing complex exponential arithmetic, thereby preventing clinical medication calculation errors.